These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 27865663)

  • 1. Hyposmolarity may be also associated with worse outcomes in patients with heart failure.
    Shen Y; Du K
    Int J Cardiol; 2017 Feb; 229():53. PubMed ID: 27865663
    [No Abstract]   [Full Text] [Related]  

  • 2. Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: the Multinational Observational Cohort on Acute Heart Failure (MOCA) study.
    Lassus J; Gayat E; Mueller C; Peacock WF; Spinar J; Harjola VP; van Kimmenade R; Pathak A; Mueller T; Disomma S; Metra M; Pascual-Figal D; Laribi S; Logeart D; Nouira S; Sato N; Potocki M; Parenica J; Collet C; Cohen-Solal A; Januzzi JL; Mebazaa A;
    Int J Cardiol; 2013 Oct; 168(3):2186-94. PubMed ID: 23538053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyponatremia and outcomes in patients with heart failure.
    Goldsmith SR
    Heart; 2012 Dec; 98(24):1761-2. PubMed ID: 23204533
    [No Abstract]   [Full Text] [Related]  

  • 4. Triple head-to-head comparison of fibrotic biomarkers galectin-3, osteopontin and gremlin-1 for long-term prognosis in suspected and proven acute heart failure patients.
    Behnes M; Bertsch T; Weiss C; Ahmad-Nejad P; Akin I; Fastner C; El-Battrawy I; Lang S; Neumaier M; Borggrefe M; Hoffmann U
    Int J Cardiol; 2016 Jan; 203():398-406. PubMed ID: 26539964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High serum osmolarity at admission determines a worse outcome in patients with heart failure: Is a new target emerging?
    Arévalo-Lorido JC; Gómez JC; Formiga F; Conde-Martel A; Carrera-Izquierdo M; Muela-Molinero A; Dávila-Ramos MF; Serrado-Iglesias A; Manzano-Espinosa L; Montero-Pérez-Barquero M
    Int J Cardiol; 2016 Oct; 221():238-42. PubMed ID: 27404682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of serum bicarbonate with long-term outcomes in patients hospitalized with heart failure.
    Nassif ME; Novak E; Rich MW
    Int J Cardiol; 2014 Dec; 177(2):673-5. PubMed ID: 25449480
    [No Abstract]   [Full Text] [Related]  

  • 7. HE4 Serum Levels Are Associated with Heart Failure Severity in Patients With Chronic Heart Failure.
    Piek A; Meijers WC; Schroten NF; Gansevoort RT; de Boer RA; Silljé HH
    J Card Fail; 2017 Jan; 23(1):12-19. PubMed ID: 27224553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased soluble ST2 is a stronger predictor of long-term cardiovascular death than natriuretic peptides in heart failure patients with reduced ejection fraction.
    Gruson D; Lepoutre T; Ahn SA; Rousseau MF
    Int J Cardiol; 2014; 172(1):e250-2. PubMed ID: 24467978
    [No Abstract]   [Full Text] [Related]  

  • 9. Validation of the Seattle Heart Failure Model in Japanese heart failure patients.
    Shiraishi Y; Sawano M; Kohno T; Nishiyama T; Maekawa Y; Sano M; Fukuda K; Kohsaka S
    Int J Cardiol; 2016 Jan; 203():87-9. PubMed ID: 26498868
    [No Abstract]   [Full Text] [Related]  

  • 10. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
    Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
    J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red blood cell distribution width as useful tool to predict long-term mortality in patients with chronic heart failure.
    Jung C; Fujita B; Lauten A; Kiehntopf M; Küthe F; Ferrari M; Figulla HR
    Int J Cardiol; 2011 Nov; 152(3):417-8. PubMed ID: 21911265
    [No Abstract]   [Full Text] [Related]  

  • 12. Challenging the two concepts in determining the appropriate pre-discharge N-terminal pro-brain natriuretic peptide treatment target in acute decompensated heart failure patients: absolute or relative discharge levels?
    Stienen S; Salah K; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Tijssen JP; Pinto YM; Kok WE
    Eur J Heart Fail; 2015 Sep; 17(9):936-44. PubMed ID: 26222618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic effect of carbohydrate antigen 125-guided therapy in patients recently discharged for acute heart failure (CHANCE-HF). Study design.
    Núñez J; Merlos P; Fácila L; Llàcer P; Bosch MJ; Bertomeu-Martínez V; García-Blas S; Montagud V; Pedrosa V; Mendizábal A; Cordero A; Miñana G; Sanchis J; Bertomeu-González V;
    Rev Esp Cardiol (Engl Ed); 2015 Feb; 68(2):121-8. PubMed ID: 25623430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum potassium decline during hospitalization for acute decompensated heart failure is a predictor of 6-month mortality, independent of N-terminal pro-B-type natriuretic peptide levels: An individual patient data analysis.
    Salah K; Pinto YM; Eurlings LW; Metra M; Stienen S; Lombardi C; Tijssen JG; Kok WE
    Am Heart J; 2015 Sep; 170(3):531-42.e1. PubMed ID: 26385037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Usefulness of Proenkephalin in Stable Ambulatory Patients With Heart Failure.
    Arbit B; Marston N; Shah K; Lee EL; Aramin H; Clopton P; Maisel AS
    Am J Cardiol; 2016 Apr; 117(8):1310-4. PubMed ID: 26916537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of blood urea nitrogen to long-term mortality in patients with heart failure.
    Cauthen CA; Lipinski MJ; Abbate A; Appleton D; Nusca A; Varma A; Goudreau E; Cowley MJ; Vetrovec GW
    Am J Cardiol; 2008 Jun; 101(11):1643-7. PubMed ID: 18489944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum soluble ST2 levels may predict the fatal outcomes in patients with chronic heart failure.
    Yao HC; Li XY; Han QF; Wang LH; Liu T; Zhou YH; Zhang M; Wang LX
    Int J Cardiol; 2015; 186():303-4. PubMed ID: 25828142
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic takotsubo syndrome with acute exacerbations may be the villain in the increase of morbidity and mortality in patients with decompensated chronic heart failure.
    Y-Hassan S
    Int J Cardiol; 2014 Apr; 172(3):609-10. PubMed ID: 24495651
    [No Abstract]   [Full Text] [Related]  

  • 19. C-reactive protein in chronic heart failure: a new predictor of survival.
    Celik T; Iyisoy A; Celik M; Yuksel UC; Kardesoglu E
    Int J Cardiol; 2009 Jul; 135(3):396-7. PubMed ID: 18501446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble neprilysin is predictive of cardiovascular death and heart failure hospitalization in heart failure patients.
    Bayés-Genís A; Barallat J; Galán A; de Antonio M; Domingo M; Zamora E; Urrutia A; Lupón J
    J Am Coll Cardiol; 2015 Feb; 65(7):657-65. PubMed ID: 25677426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.